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Abstract. – OBJECTIVE: This review paper aims 
to summarize the current state of knowledge on 
the role of the pneumologist in the diagnosis and 
respiratory treatment of children affected by ob-
structive Sleep Disordered Breathing (SDB). 
MATERIALS AND METHODS: A literature re-
view has been performed on the following topics: 
obstructive SDB and its clinical entities, indica-
tions for respiratory treatment of pediatric SDB, 
and Continuous Positive Airway Pressure (CPAP) 
and Noninvasive Positive Pressure Ventilation 
(NIPPV) treatment approach to obstructive SDB.
RESULTS: OSDB is related to obesity, cranio-
facial pathologies, neuromuscular disorders and, 
most commonly, adentotonsillar hypertrophy. 
Adenotonsillectomy is the first-choice treatment 
in children with obstructive apnea secondary to 
adenotonsillar hypertrophy. CPAP and NIPPV are 
recommended in cases where Obstructive Sleep 
Apnea (OSA) persists after surgery or when sur-
gery is contraindicated. Treatment interventions 
are usually implemented gradually by separately 
addressing each abnormality that would predis-
pose to obstructive SDB, then reevaluating after 
each intervention to detect any residual disease 
and to assess the need for additional treatment. 
CONCLUSIONS: Many pediatric patients con-
tinue to experience problems and symptoms 
such as hypersomnia and apnea after ade-
notonsillectomy and need CPAP/NIPPV treat-
ment. Current knowledge is still incomplete, 
especially with regard to the mechanisms of 
pathogenesis of pediatric OSA, the factors af-
fecting pediatric OSA, and the phenotypic vari-
ability of the disease. A better understanding of 
these aspects would contribute to the develop-
ment of new therapies.
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Introduction
Pediatric obstructive sleep disordered breath-
ing (SDB) comprises a range of obstructive respi-
ratory disorders during sleep; characteristic clin-
ical indications include snoring and/or increased 
respiratory effort secondary to increased risk of 
upper airway resistance and pharyngeal collapse1. 
These phenomena may cause hypoxia, hypercar-
bia, increased respiratory efforts, considerable 
intrathoracic pressure changes, and sleep frag-
mentation2. Obstructive sleep apnea (OSA) is one 
of the most common causes of SDB in children. 
It affects neurocognitive development and the 
child’s general state of health. Moreover, SDB has 
a multifactorial etiopathogenesis and its correct 
diagnosis and therapy require a multidisciplinary 
approach that involves otorhinolaryngologists, 
neurologists, pneumologists, maxillofacial sur-
geons, dentists, cardiologists and pediatricians3. 
The term “obstructive SDB” is used whenev-
er intermittent obstruction symptoms in the upper 
airways are observed during sleep; however, the 
severity of the disease is determined by studying 
daily drowsiness, along with objective tests like poly-
somnography (PSG). In a recent meta-analysis, the 
prevalence of regular snoring in children was 7.45%, 
while the presence of OSA syndrome showed a 
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frequency ranging from 1% to 4%. The apnea-hypo-
pnea index (AHI) is the polysomnographic parameter 
that measures SDB severity by the number of mixed, 
obstructive, and central apneas and hypopneas per 
hour during a complete sleep4,5. 
The aim of this review article is to evaluate 
the role of the pneumologist in the diagnosis and 
respiratory treatment of children affected by ob-
structive SDB.
Materials and Methods
A literature review has been performed on arti-
cles retrieved from PubMed and Scopus from the last 
30 years on the following topics: obstructive sleep 
disordered breathing and its clinical entities, indica-
tions for respiratory treatment of pediatric SDB, and 
Continuous Positive Airway Pressure (CPAP) and 
Noninvasive Positive Pressure Ventilation (NIPPV) 
treatment approach to obstructive SDB.
Results
Obstructive Sleep Disordered Breathing 
and Its Clinical Entities
The spectrum of pediatric obstructive SDB 
has four degrees of severity 6:
Primary snoring: the mildest and most preva-
lent manifestation. Habitual snoring is defined as 
snoring that occurs more than 3 nights per week 
without apnea, hypopnea, frequent arousal, or gas 
exchange abnormalities.
Upper Airway Resistance Syndrome (UARS): in-
volves snoring, increased respiratory effort, and fre-
quent arousal, without recognizable presence of ob-
structive events or gas exchange abnormalities.
Obstructive hypoventilation: characterized by 
nocturnal snoring with a high increase of carbon 
dioxide in the blood in the absence of recogniz-
able obstructive events.
OSA syndrome: manifests itself with frequent 
events of partial or complete obstruction of the 
upper airways (hypopnea, obstructive or mixed 
apnea) with normal oxygenation, ventilation and 
sleep interruption.
Indications for Respiratory 
Treatment of Pediatric SDB
The primary standard test to diagnose ob-
structive SDB and assess its severity is PSG 1,7. 
PSG allows for objective diagnosis, classification 
and severity of the pathologic condition. AHI 
total sleep time (TST), the number of mixed, 
obstructive and central apneas and hypopnea per 
hour of total sleep time, is the PSG parameter 
used to diagnose and quantify the severity of 
SDB. AHI TST tracks obstructive, mixed apnea 
or obstructive hypopnea events per hour of sleep, 
hypoventilation during sleep (when PaCO2 > 
50 mmHg for > 25% of TST), isolated snoring, 
paradoxical thoracoabdominal motion, and/or 
flow limitation. Most sleep centers consider an 
obstructive AHI ≤ 1 episode per hour TST to be 
normal, 1 < AHI ≤ 5 as mild OSA, 5 < AHI ≤ 10 
as moderate OSA and AHI >10 as severe OSA.
PSG is indicated in children with symptoms 
of obstructive SDB who have not yet undergone 
adenotonsillectomy, especially in the presence of 
obesity. PSG has also been recommended after 
adenotonsillectomy in patients with persistent 
symptoms of OSA syndrome despite surgery7.
When PSG is not available, possible alterna-
tives include nocturnal oximetry studies, nocturnal 
cardiorespiratory PSG recording, and home sleep 
testing (HST) and ambulatory PSG recording8.
Nocturnal oximetry studies consist in continu-
ous recording with trend analysis and an average 
time of 3 seconds or less. Oximetry studies have 
high specificity but low sensitivity in the diagnosis 
of pediatric OSA. According to the McGill crite-
ria, the diagnostic elements of oximetry studies 
can be summarized as three or more clusters of 
desaturation ≥ 4%, with at least three desaturations 
at < 90% being considered pathological. However, 
the rate of false negative or inconclusive results is 
high. In a recent study on 589 patients suspected 
of OSA, Hornero et al9 have demonstrated that the 
automated analysis based on the neural network of 
oximetry saturation recordings provides a compre-
hensive identification of the severity of OSA among 
children with a high probability of OSA pre-testing. 
These results strongly suggest that nocturnal oxim-
etry can provide a simple and effective diagnostic 
alternative to nocturnal PSG, leading to prompter 
interventions and potentially better results.
Nocturnal cardiorespiratory PSG recording is 
a regular PSG exam without the electroencepha-
lography, electromyography and electrooculogra-
phy sensors. It is easier than PSG to perform and 
to set. Some authors have reported good results 
with in-lab PSG10,11.
HST and ambulatory PSG recording are also 
alternative studies to PSG. Outpatient cardiorespi-
ratory nocturnal PSG has proven to be effective in 
guiding the diagnosis of obstructive SBD. Cardio-
respiratory nocturnal PSG tests are considered as a 
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less expensive alternative to in-lab PSG; moreover, 
the results may be more representative of the child’s 
typical home sleep. Comparison data with in-lab 
PSG are still limited, but results from a recent study 
by Alonso-Alvarez et al12 comparing outpatient HST 
with in-lab PSG in 50 children clinically suspected 
of OSA, has shown promising diagnostic potential.
In addition to PSG, self-administered ques-
tionnaires that investigate the presence of char-
acteristic symptoms, risk factors and predictors 
of OSA can be used; however, they are mainly 
used in the adult population13-15 although some 
have been applied to pediatric patients as well16.
Ventilatory Treatment 
for Obstructive SDB
Treatment for children with obstructive SDB 
may be surgical or non-surgical; the choice de-
pends on the underlying etiology. The European 
Respiratory Society Taskforce 1 recommends a 
gradual approach to treatment, up to full reso-
lution of OSA. The taskforce recommends treat-
ment in children with AHI > 5; in children with 
AHI between 1 and 5, ventilatory treatment may 
be initiated in the presence of comorbidity. In the 
common case of significant adenotonsillar hyper-
trophy, the first step in treating pediatric SDB is 
adenotonsillectomy. In OSA pediatric patients 
without significant adenotonsillar hypertrophy, 
positive airways pressure therapy is recommend-
ed to keep the upper airways open throughout 
the respiratory cycle, improve lung function and 
reduce breathing. Starting CPAP treatment in 
children may be difficult; time must be taken 
to educate the parents on the importance of the 
treatment and to make sure they are involved 17.
Indications for CPAP and NIPPV are residu-
al OSA after adenotonsillectomy (AHI > 5) and 
OSA syndrome related to obesity, craniofacial ab-
normalities, or neuromuscular disorders. If noctur-
nal hypoventilation occurs (end-tidal carbon dioxide 
tension PCO2 > 50 mmHg for > 25% of total sleep 
time or peak end-tidal PCO2 ≥ 55 mmHg), NIPPV 
is preferred 1. Indications are summarized in Table 
I. NIPPV of the airway has been found to produce 
improved gas exchange, along with improvements in 
attention deficit, sleepiness, behavior, and quality of 
life. Treatment with CPAP/NIPPV should be initiated 
in the hospital. Several nasal/oronasal masks should 
be tried to choose the one that the child accepts 
best. Treatment should be started in daytime to ac-
commodate incremental pressures. In some cases, 
in-hospital application needs to be for several nights, 
depending on the child’s tolerance of CPAP/NIPPV.
Discussion
The pneumologist plays a central role in the 
respiratory treatment of children affected by ob-
structive SDB when the surgical approach is con-
traindicated or, more commonly, OSA persists after 
surgery. In fact, many pediatric patients continue 
to experience problems and symptoms such as 
hypersomnia and apnea after adenotonsillectomy 
and need CPAP/NIPPV treatment. Furthermore, 
positive airway pressure therapy is recommended 
in all cases of SDB secondary to obesity, cranio-
facial pathologies, and neuromuscular disorders.
Treatment with CPAP/NIPPV can be started in a 
team approach to make the process fun and reduce 
anxiety. When night and day PaCO2 is elevated, 
which occurs in children with other comorbidities 
such as neuromuscular disease, craniofacial syn-
dromes or obesity hypoventilation, NIPPV treat-
ment may be preferentially indicated. In NIPPV, 
the machine offers greater inspiratory/expiratory 
pressure comfort, so is recommended when the 
child does not tolerate CPAP. Biphasic positive 
airway pressure (BiPAP) treatment may also be 
better tolerated in children who do not tolerate 
CPAP because of better positive exhalation pressure 
levels. CPAP and NIPPV complications include 
nasal congestion, rhinorrhea, epistaxis, skin facial 
erythema due to the mask, and discomfort due to air 
build-up in the abdomen. It is important to monitor 
adherence to CPAP or NIPPV and to manage com-
plications to optimize patient adherence. Regular 
Table I. Indications for ventilatory treatment of obstructive Sleep Disordered Breathing (SDB).
– AHI > 5 episodes (CPAP/NIPPV).
– CPAP or NIPPV (for nocturnal hypoventilation) may be beneficial in cases of AHI 1–5 episodes in the presence of: 
 morbidity from the cardiovascular system; morbidity from the central nervous system; enuresis; somatic growth delay
 or growth failure; decreased quality of life; risk factors for SDB persistence.
– SDB respiratory treatment (CPAP or NIPPV) is a priority in the presence of: serious craniofacial abnormalities; 
 neuromuscular disorders; achondroplasia; Chiari malformation; Down syndrome; mucopolysaccharidoses; 
 Prader-Willi syndrome.
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long-term control should be performed with respect 
to respiratory work pressure and device interface 
in order to prevent cutaneous decubitus. General-
ly, PSG recording is recommended 6 weeks after 
adenotonsillectomy. Children treated by CPAP or 
NIPPV should be reviewed at least every 12 months 
after initial treatment.
Conclusions
CPAP is recommended in cases where OSA 
persists after surgery, when surgery is contrain-
dicated or in patients with SDB secondary to obe-
sity, craniofacial pathologies, and neuromuscular 
disorders. CPAP/NIPPV treatment is complex 
and requires many multidisciplinary specialists, 
as many children do not tolerate CPAP. Our 
knowledge is still incomplete, especially with 
regard to the mechanisms of pathogenesis of pe-
diatric OSA, the factors affecting pediatric OSA, 
and the phenotypic variability of the disease. 
A better understanding of these aspects would 
contribute to the development of new therapies.
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